Skip to content

Risk factors for metastasis and long-term outcomes in endoscopic curability C-2 after endoscopic submucosal dissection for undifferentiated type early gastric cancer in Japanese cohort

Risk factors for metastasis and long-term outcomes in endoscopic curability C-2 after endoscopic submucosal dissection for undifferentiated type early gastric cancer in Japanese cohort - A study of risk factors for metastasis and long-term prognosis in eCuraC-2 after??endoscopic submucosal dissection for??undIfferentiated early gastric??Cancer (construction of undifferentiated??version of eCura system)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000055524
Enrollment
800
Registered
2024-09-18
Start date
2024-08-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-curative resection of undifferentiated-type early gastric cancer

Interventions

None listed

Sponsors

Kitakyushu Municipal Medical Cancer
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: non-curative resection of undifferentiated-type early gastric cancer

Exclusion criteria

Exclusion criteria: (1) synchronous or metachronus EGC treated by ESD that did not meet the curative criteria of Japanese Gastric Cancer Treatment Guidelines, (2) ESD in the remnant stomach or gastric tube, (3) additional treatment except surgical resection, (4) invasion of the muscularis propria (MP) or deeper in the pathology of the surgically or endoscopically specimen or (5) missing data.

Design outcomes

Primary

MeasureTime frame
The rate of LNM in patients received radical surgery after ESD, and univariate and multivariate analyses were performed to evaluate the relationship between LNM clinicopathological factors.

Countries

Japan

Contacts

Public ContactKazuo Shiotsuki

Kanagawa Cancer Cancer Department of Gastroenterology

k.shiotsuki19881014@gmail.com045-520-2222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026